| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | US20040053139 Organic borate compounds and the nonaqueous electrolytes and lithium secondary batteries using the compounds |
| 03/18/2004 | US20040051088 Mixture of a phosphonite with other components |
| 03/18/2004 | DE10242636A1 Production of dialdehydes and/or ethylenically unsaturated monoaldehydes, useful as intermediates, comprises hydroformylation of a compound having two ethylenically unsaturated double bonds using a Group VIII metal-pnicogen chelate catalyst |
| 03/18/2004 | DE10242351A1 Chirale Monophosphorverbindungen und deren Übergangsmetallkomplexe Chiral Mono phosphorus compounds and their transition metal complexes |
| 03/18/2004 | DE10241373A1 Oberflächenmodifizierte Phosphinsäuresalze Surface-modified phosphinates |
| 03/18/2004 | CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers |
| 03/17/2004 | EP1398319A1 Chiral monophosphorus compounds and transition metal complexes thereof |
| 03/17/2004 | EP1188760B1 Ip3 receptor ligands |
| 03/17/2004 | EP1133356B1 Hydroformylation process using chlorophosphite-metal catalyst system |
| 03/17/2004 | EP1051181B1 Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof |
| 03/17/2004 | EP1005452B1 Anionic alkoxylate surfactant |
| 03/17/2004 | EP0655917B1 Crystalline amifostine compositions and methods for the preparation and use of same |
| 03/17/2004 | CN1482130A Process for making glyphosate acid ammonium salt by catalyzing and oxidizing double gly phosphine under homogeneous phase |
| 03/17/2004 | CN1482122A Intermediates for producing 2-thiosubstituted carbapenems |
| 03/17/2004 | CN1142171C 9-[2-[[[di (trimethylacetoxyl) methyl phosphoroso] methoxy]-ethyl] adenine crystal and its prepn and crystal application |
| 03/17/2004 | CN1142170C 9-[2-[[[di (trimethylacetoxyl) methyl] phosphoroso] methoxy]-ethyl] adenine crystal and its prepn and crystal application |
| 03/17/2004 | CN1142169C Improved prep. of 3-trifluoro methyl-5-hydroxy-pyrazole phosphate derivatives in the presence of hydrosolvent |
| 03/17/2004 | CN1142168C Process for preparing (cycloheptylamino) methylene biphosphonic acid |
| 03/17/2004 | CN1142167C Method for producing salts of dialkylphosphonate |
| 03/16/2004 | US6706926 Enantioselective hydrogenation catalysts |
| 03/16/2004 | US6706907 Treatment with epoxy compound; storage stability, heat resistance, lower acid value, nonhydrolyzing |
| 03/16/2004 | US6706829 Methods of polymerizing ethylene and styrene copolymers with substituted pyridyl amine catalysts and catalysts therefor |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706699 Quinolines and uses thereof |
| 03/16/2004 | US6706698 Anticholesterol agents |
| 03/16/2004 | US6706662 Catalyst for dehydrogenating primary alcohols to make carboxylic acid salts |
| 03/16/2004 | US6706280 Drug targeting with liposomes and magnetic resonance imaging contrast media for diagnostics |
| 03/16/2004 | CA2351338C Improved method for refining vegetable oil |
| 03/16/2004 | CA2139348C Improved chemiluminescent 1,2-dioxetanes |
| 03/11/2004 | WO2004020447A1 Phosphorous ester compound, process for producing the same, and use thereof |
| 03/11/2004 | WO2004020446A2 N-(2, 2, 2-trichloro-1-dialkylphosphonatoethyl) (meth)acrylamide, production thereof, use thereof as a comonomer for the production of methacryl foams, and self-extinguishing methacryl foams produced therewith |
| 03/11/2004 | WO2004020389A1 Method for the enantioselective hydrogenation of amino alcohols |
| 03/11/2004 | WO2004020381A1 Process for preparing aldehyde compounds |
| 03/11/2004 | WO2004020079A1 Method for preparing colloidal solution of bismuth sodiun tartrate |
| 03/11/2004 | WO2004019859A2 Phosphonamide and phosphonamide blend compositions and method to treat water |
| 03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
| 03/11/2004 | WO2003068784A3 Acyl- and bisacylphosphine derivatives |
| 03/11/2004 | WO2003062247A3 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace) |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049287 Endosseous implant |
| 03/11/2004 | US20040049063 Encapsulated with a wax or synthetic resin surface layer; use as flame retardants for polymers |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040049036 From diphenyl (4-(4-fluorophenyl)-6-isopropyl-2-(methyl-(methyl sulfonyl)amino)pyrimidin-5-ylmethyl)phosphine and tert-butyl-2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl) acetate; removal of tert-butyl group to form acid or salt |
| 03/11/2004 | US20040048908 E.g., 3-(5-(3,4-dichlorophenyl)- 4-isoxazolyl)propan-1-ol; prophylaxis or treatment of diabetes, impaired glucose tolerance or diabetic complications |
| 03/11/2004 | US20040048894 Compounds which mimic the chemical and biological properties of discodermolide |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048834 Antitumoral compounds |
| 03/11/2004 | US20040048797 Regulation of TNF-alpha |
| 03/11/2004 | US20040047903 For use in therapy of cancer |
| 03/11/2004 | DE10240803A1 Verfahren zur Herstellung von Phosphiten und Übergangsmetallkomplexen A process for the production of phosphites and transition metal complexes |
| 03/11/2004 | DE10240212A1 Herstellung von N-(2, 2, 2-Trichlor-1-dimethyl-phosphonatoethyl)methacrylamid, seine Verwendung als Comonomer bei der Herstellung von Methacrylschäumen und damit hergestellte, selbstverlöschende Methacrylschäume Preparation of N- (2, 2, 2-trichloro-1-dimethyl-phosphonatoethyl) methacrylamide, its use as a comonomer in the preparation of Methacrylschäumen produced and thus, self-Methacrylschäume |
| 03/10/2004 | EP1396524A1 Surface modified phosphinic acid salts |
| 03/10/2004 | EP1395357A2 Compositions of alkanolamine salts of alkyl phosphate esters |
| 03/10/2004 | EP1395265A2 Combretastatin a-3 prodrug |
| 03/10/2004 | EP1230200B1 C13 alcohol mixture and functionalised c13 alcohol mixture |
| 03/10/2004 | EP1200437B1 Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 03/10/2004 | EP1112275B9 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 03/10/2004 | CN1481373A 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 03/10/2004 | CN1481368A Gyrase imhibitors and uses thereof |
| 03/10/2004 | CN1480460A Method for preparing N-phosphine carboxymerhyl-glycin |
| 03/10/2004 | CN1480453A Compound of fluorene class containing dual hetero atoms as well as its synthetic method and application |
| 03/10/2004 | CN1141308C Method for alkyalting elemental phosphor |
| 03/09/2004 | US6703518 Fluoride-releasing compositions |
| 03/09/2004 | US6703507 Nonaqueous liquid comprising the ammonium salt of a sulfonated or carboxylated phosphite ligand; use as a media for chemical reactions, including those using transition metal catalysts |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703404 Nitric oxide synthase inhibitors |
| 03/09/2004 | US6703391 Quinoxalinedione derivatives, their preparation and use |
| 03/09/2004 | US6702705 Prodrugs activated by targeted catalytic proteins |
| 03/04/2004 | WO2004018487A1 Chiral organosilicon hydrides |
| 03/04/2004 | WO2003097856A3 Plating media |
| 03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |
| 03/04/2004 | WO2003043735A3 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions |
| 03/04/2004 | WO2003000173A3 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 03/04/2004 | US20040044238 Reducing ketones using polydimethylsiloxane as reducing agents; froming alcohols; using complex catalyst |
| 03/04/2004 | US20040044190 Purification of oligomers |
| 03/04/2004 | US20040044168 Phosphorus- and nitrogen-containing resin hardener and a flame retarding resin composition containing said hardener |
| 03/04/2004 | US20040044059 Tubulin binding ligands and corresponding prodrug constructs |
| 03/04/2004 | US20040044052 N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040043989 Therapy for drug resistant bacteria; topoisomerase inhibitor |
| 03/04/2004 | US20040043969 Tubulin binding agents and corresponding prodrug constructs |
| 03/04/2004 | US20040043967 Novel process for making bisphosphonic acids using diluents other than halogenated hydrocarbons |
| 03/04/2004 | US20040043636 Systems and methods for forming tantalum oxide layers and tantalum precursor compounds |
| 03/04/2004 | US20040043388 Compositions and methods for isolating ligand binding polypeptides for a user-specified ligand, and for isolating small molecule ligands for a user-specified target polypeptide using an improved class of hybrid ligand compounds |
| 03/04/2004 | US20040043149 Vapor deposition of metal oxides, silicates and phosphates, and silicon dioxide |
| 03/04/2004 | US20040040911 Phosphonamide and phosphonamide blend compositions and method to treat water |
| 03/04/2004 | US20040040840 Controller for redox system |
| 03/04/2004 | DE10241256A1 New tetrahydrofuran bisphosphines useful for preparing transition metal complexes useful as catalysts for preparing stereoisomer-enriched compounds, e.g. pharmaceuticals and agrochemicals |
| 03/04/2004 | DE10238114A1 Optisch aktive Diamine und deren Anwendung in katalytischen Prozessen Optically active diamines and their application in catalytic processes |
| 03/03/2004 | EP1394185A1 Derivative of polyvinylpyridine |
| 03/03/2004 | EP1394168A1 Process for the preparation of phosphites and complexes with transition metals |
| 03/03/2004 | EP1394163A1 Bicycloamide derivatives |
| 03/03/2004 | EP1392868A1 Method for the synthesis of dna sequences |
| 03/03/2004 | EP1392736A2 Acid macromonomers and their method of preparation |
| 03/03/2004 | EP1392684A1 Thiazole compounds useful as inhibitors of protein kinases |
| 03/03/2004 | EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
| 03/03/2004 | EP0986386B1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
| 03/03/2004 | EP0853617B1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |